They aren’t. https://www.rand.org/pubs/research_reports/RRA788-1.html:
“Although the ratio of U.S. to other-country prices varied depending on the comparison country and insulin category, U.S. prices were always higher (often five to ten times higher) than those in other countries.“
“Other countries” includes Canada and Germany, so they didn’t look at particularly poor countries. The linked PDF says
“The average U.S. manufacturer price per standard unit across all insulins was $98.70, compared with $6.94 in Australia, $12.00 in Canada, $7.52 in the United Kingdom, and $8.81 across all non-U.S. OECD countries combined”